Your browser doesn't support javascript.
loading
Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results.
Cervantes, Francisco; Isola, Ignacio M; Alvarez-Larrán, Alberto; Hernández-Boluda, Juan-Carlos; Correa, Juan-Gonzalo; Pereira, Arturo.
Afiliação
  • Cervantes F; Hematology Department, Hospital Clínic, IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Spain. fcervan@clinic.ub.es.
  • Isola IM; Hematology Department, Hospital Clínic, IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Spain.
  • Alvarez-Larrán A; Hematology Department, Hospital del Mar, Barcelona, Spain.
  • Hernández-Boluda JC; Hematology and Medical Oncology Department, Hospital Clínico Universitario, Valencia, Spain.
  • Correa JG; Hematology Department, Hospital Clínic, IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Spain.
  • Pereira A; Hematology Department, Hospital Clínic, IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Ann Hematol ; 94(11): 1791-6, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26122869

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Danazol / Mielofibrose Primária / Anemia Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Danazol / Mielofibrose Primária / Anemia Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article